Money5 min read
Eli Lilly Earnings Q3 2026: LLY Stock, Zepbound and Guidance
Eli Lilly beat Q3 2026 estimates with $24.4 billion in revenue and raised its full-year sales outlook to $91-92 billion. Here's what drove LLY stock, plus Zepbound, Mounjaro and Foundayo sales.